» Articles » PMID: 30484062

Early Surgery with Aggressive Surgical Approach to Improve 6-month Outcomes in Patients with Active Infective Endocarditis: Contribution of Cerebral Preoperative Magnetic Resonance Imaging

Overview
Date 2018 Nov 29
PMID 30484062
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: We investigated the hypothesis that early surgery for infective endocarditis (IE) attenuates the rate of death or embolic events and does not increase the rate of relapse or postoperative valvular dysfunction (PVD) at 6 months.

Methods: 21 consecutive patients who underwent surgical treatment of IE were prospectively included. We assessed 6-month postoperative clinical outcomes by comparing early surgery (Group E, surgery within 72 h) and conventional treatment (Group C). Nine patients (43%) were assigned to Group E based on a combination of preoperative evaluation parameters, including the findings of cerebral magnetic resonance imaging (MRI), which was performed in all patients with left-sided IE.

Results: Six surgical plans (5 advancements and 1 postponement) were modified by routine MRI. Although preoperative echocardiography did not confirm all annular invasions, the rate of periannular infection, which was treated by pericardial annular patch plasty (56%) in patients with native-valve IE, was higher in Group E than C (P = 0.006). Early surgery based on MRI findings resulted in no postoperative embolic events or cerebral bleeding. The 6-month mortality rate was 0% in both groups, although the calculated 6-month IE mortality rate was 49.2 ± 25% and 28.8 ± 18%, respectively. No recurrence of IE or PVD occurred in Group E. The 6-month rate of freedom from composite events was 100% in Group E.

Conclusions: Aggressive treatment (periannular resection and disuse of a prosthetic annuloplasty ring) and optimal antibiotic therapy based on intraoperative microorganisms, even in patients who underwent early surgery, reduced the 6-month relapse and PVD rates.

Citing Articles

Current Challenges in the Management of Infective Endocarditis.

Cuervo G, Escrihuela-Vidal F, Gudiol C, Carratala J Front Med (Lausanne). 2021; 8:641243.

PMID: 33693021 PMC: 7937698. DOI: 10.3389/fmed.2021.641243.


Diabetes Mellitus: An Independent Risk Factor of In-Hospital Mortality in Patients with Infective Endocarditis in a New Era of Clinical Practice.

Lin C, Chua S, Chung S, Hang C, Tsai T Int J Environ Res Public Health. 2019; 16(12).

PMID: 31242695 PMC: 6617149. DOI: 10.3390/ijerph16122248.

References
1.
Argyriadis P, Shafy A, Cohen A, Berrebi A, Loulmet D, Chachques J . Partial replacement of the tricuspid valve by mitral homografts in acute endocarditis. Ann Thorac Surg. 2002; 73(6):1808-12. DOI: 10.1016/s0003-4975(02)03574-9. View

2.
Hasbun R, Vikram H, Barakat L, Buenconsejo J, Quagliarello V . Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003; 289(15):1933-40. DOI: 10.1001/jama.289.15.1933. View

3.
Fowler Jr V, Miro J, Hoen B, Cabell C, Abrutyn E, Rubinstein E . Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA. 2005; 293(24):3012-21. DOI: 10.1001/jama.293.24.3012. View

4.
Ruttmann E, Legit C, Poelzl G, Mueller S, Chevtchik O, Cottogni M . Mitral valve repair provides improved outcome over replacement in active infective endocarditis. J Thorac Cardiovasc Surg. 2005; 130(3):765-71. DOI: 10.1016/j.jtcvs.2005.03.016. View

5.
Bonow R, Carabello B, Kanu C, de Leon Jr A, Freed M, Gaasch W . ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the.... Circulation. 2006; 114(5):e84-231. DOI: 10.1161/CIRCULATIONAHA.106.176857. View